***********************************
Brakke Consultingの
Animal Health News & Notes for February 7, 2014
Copyright © Brakke Consulting, Inc.
編集者: リン・フォンドン DVM MBA
************************************
ニュース:
Brakke Consulting ニュース
2014 Industry Overview – online registration ends Feb. 12!
中国と日本の動物用医薬品市場の概要
アニマルヘルスジョブズ
収益ニュース
アバキシス
ビオニチェ
アイデックス
メルク
メリアル
ＭＷＩ
オリオン
ペットメッドエクスプレス
その他のニュース
アバキシス
イメージワークス
ジャガーアニマルヘルス
ケインバイオテック
メルク
現代の獣医治療
パターソン
TNG Pharmaceuticals
***********************************
KC動物保健回廊
動物衛生投資フォーラム
プレゼンターの応募受付中
KC 動物保健回廊は現在、ミズーリ州カンザスシティで 8 月 26 日に開催される 2014 KC 動物保健投資フォーラムでの発表申し込みを受け付けています。
今年で6年目を迎えるこのフォーラムは、動物衛生分野の初期段階にある企業が、そのビジョン、ビジネスプラン、テクノロジーを潜在的な投資家に提示できる世界でも数少ない機会の1つです。
選考委員会は以下の基準を満たす企業を検討します。
– $50万～$20万の資金を募集
– 5～7年以内に$20百万の収益予測
応募締め切りは4月18日です。応募するには、 http://www.kcanimalhealthforum.com/index.php/apply-to-present/詳細については、Kimberly Youngまでお問い合わせください。 メールアドレス.
************************************
企業業績発表
> Merck announced financial results for the full year 2013. Global sales for the full year of 2013 were $3,362 million, a decline of 1%, including a 2% negative impact from foreign exchange. Lower sales of ruminant products were partially offset by growth in companion animal and poultry products. (company website)
> Sanofi reported financial results for the full year 2013. Sales of animal health unit Merial decreased 5% to EUR 1,985 million ($2,733 million) in 2013 reflecting increased competition to Frontline. (company website)
> Orion reported results for the full year 2013. The Animal Health division’s revenues were EUR 71 million ($96 million), an increase of 3% compared to the previous year. (Animal Pharm)
> Bioniche Life Sciences Inc. announced financial results for the second quarter of Fiscal 2014 (ended December 31, 2013). Revenues for the Animal Health business unit were $8.3 million, a decline of 6% compared to the same period in Fiscal 2013. Animal Health net income was $2.1 million, as compared to net income of $1.1 million in Q2, Fiscal 2013. (WallStreetJournal.com)
> IDEXX Laboratories, Inc. reported financial results for the full year 2013. Revenues increased 6.5% to $1,377 million. Net income for the year increased 6% to $188 million. Companion Animal Group (CAG) revenue for the year increased 7% to $1.15 billion. (company website)
> Abaxis, Inc. reported financial results for the third fiscal quarter ended December 31, 2013. Veterinary market revenues were $32.2 million, a decline of 19% compared to the comparable period in the prior year. (Sacbee.com)
> MWI Veterinary Supply, Inc. announced financial results for its first quarter ended December 31, 2013. Total revenues were $687 million for the quarter, an increase of 20% compared to the same period in the prior fiscal year. Net income was $18.4 million for the quarter, an increase of 10%. Excluding the impact of the acquisition of the assets of IVESCO Holdings, LLC which closed on November 1, 2013, revenue growth was 10% in the US for the quarter compared to the same period in the prior fiscal year. (company website)
> PetMed Express, Inc. announced its financial results for the fiscal third quarter ended December 31, 2013. Net sales were $50 million, an increase of 1% compared to the comparable period in the prior year. Net income was $4.5 million, a decline of 2%. (company website)
************************************
明確化
Zoetis’ newly launched Apoquel (oclacitinib tablet) is labeled for twice daily dosing in dogs for up to two weeks; after 14 days, Apoquel may be given once a day for maintenance purposes.
************************************
株式会社ブラッケコンサルティング
2014年業界概要
EARLY REGISTRATION ENDS FEB. 12!
Brakke Consulting は、ネバダ州ラスベガスで開催される西部獣医カンファレンスで 2014 年の米国動物医療業界の概要を発表します。日付は次のとおりです。
• WVC: 2 月 18 日火曜日、午後 2:00 ～ 4:00、Four Seasons。
WVCに登録するには、 ホームページ and scroll down to the “What’s New” box. The price is $385 per person for online registration, available through WEDNESDAY, FEBRUARY 12; late registration is $425.
************************************
企業ニュースリリース
> Merck Animal Health introduced Once PMH IN, the only intranasal vaccine to deliver dual bacterial pneumonia protection in healthy beef and dairy cattle. Once PMH IN aids in the control of respiratory disease caused by Mannheimia haemolytica and in the prevention of disease caused by Pasteurella multocida. (company press release)
> Abaxis, Inc. announced that the Department of the Army has awarded the company a contract to provide veterinary diagnostic laboratory services to the Veterinary Services Central Fund (VSCF). This contract provides point-of-care laboratory diagnostic instruments and reagents as well as reference laboratory services to approximately 118 Army veterinary activities within and outside the continental United States. The period of performance under this contract is for one year, effective immediately, with options for four additional one-year periods. (WallStreetJourjal.com)
> Jaguar Animal Health, Inc. announced an initial $2 million closing of its Series A round of financing. BioVeda China Fund (“BVCF”), a private equity and growth capital investor based in China, funded the initial closing and will invest another $3 million by the end of February 2014. Jaguar is focused on the development and commercialization of health solutions for the global veterinary marketplace from plants used traditionally in rain forest areas. (Marketwatch)
> TNG Pharmaceuticals, Inc. announced that it completed a $4.6 million Series A Preferred Stock financing on December 31, 2013. The company’s FlyVax product is a patented vaccine designed to significantly reduce the damage caused by horn flies, thus improving the health and wellbeing of cattle. (company press release)
> Kane Biotech Inc. announced it has received a total of $397,500 from the exercising of 2,650,000 warrants at $0.15 per share from warrant holders. The warrants were issued on December 14, 2012 as part of a previously announced financing. (Marketwatch)
> Blackstone Holdings, LLC announced it has acquired the veterinary division of ImageWorks Corporation/AFP, which sell digital dental imaging equipment. The new company will operate as ImageWorks Veterinary. Financial terms were not disclosed. (Floridanewswire.com)
> Patterson Veterinary introduced the new Versa II veterinary anesthesia machine. The Versa II, which is manufactured by Patterson Veterinary, is a small animal anesthesia machine designed to meet all the demands of a veterinary practice. (company press release)
> CANADA Modern Veterinary Therapeutics, LLC announced that the Canadian Veterinary Drugs Directorate (VDD) has approved Cloprostenol Veyx (cloprostenol injection) in cattle for treating certain clinical conditions which delay breeding, manipulating the estrous cycle to better fit specific management practices, and inducing abortion. (company press release)
***********************************
株式会社ブラッケコンサルティング
アニマルヘルスジョブズ
資格のある求職者を見つけるのに最適なウェブ上の場所です。
アニマルヘルスジョブズ is the premier recruiting web site for the animal health industry. Our database of registered job seekers has grown to over 19,000 resumes, and our website currently has over 115 job postings.
有能な専門家が必要な場合は、まず Brakke Consulting と Animal Health Jobs を検討してください。
アニマルヘルスジョブズ
***********************************
動物の健康ニュース
> US – PEDV Iowa State University Veterinary Diagnostic Laboratory announced it has identified a strain of Porcine Epidemic Diarrhea virus that is not similar to the cases identified in US swine since April 2013. Based on the data currently available, it appears unlikely that this strain is a mutant evolved from PEDV previously identified in US swine. Determination of the entire genome sequences of these new PEDVs are in progress and will help determine the origin of the viruses. (Farmfutures.com)
> US – HEARTWORM GUIDELINES The American Heartworm Society (AHS) has revised its guidelines for dogs and cats. The revised guidelines note the documented presence of resistant subpopulations of heartworms, as well as changes in testing and treatment recommendations. The revised AHS guidelines can be found at www.heartwormsociety.org（獣医アドバンテージ）
***********************************
株式会社ブラッケコンサルティング
日本と中国の動物用医薬品市場
2014年2月18日火曜日
ラスベガス
Brakke Consulting, Inc. は、日本と中国の動物医療市場の概要を紹介する 2 時間のセミナーを開催します。AHRMS, Inc. の社長兼 CEO である Yuki Ujimasa 獣医師、理学修士が、日本の動物医療業界の最近の重要な動向について説明します。VaxiAm, LLC の代表取締役である Jishu Shi 獣医師、理学博士が、中国の動物医療業界の概要を説明します。
セミナーはラスベガスのフォーシーズンズホテルで午前10時から午後12時まで開催されます。2時間のセミナーの登録料は1人あたり$300です。登録するには、Brakke Consulting（972）243-4033に電話し、Jane Morganに問い合わせるか、電子メールでお問い合わせください。 お問い合わせ .
ブラッケコンサルティング
***********************************
BRAKKEコンサルティングの視点
This week some of the companies reported nice revenue gains for 2013 while others reflected some of the challenges in the marketplace. There are still a couple of the leading companies to report; however, if these reports are close to expectations, our estimate of a 2.5% growth in the industry for 2013 should be fairly accurate.
While there were no mega deals reported this week, the stories related to the continued investments by investment firms in early stage companies and technologies are encouraging. The increased interest by the financial community in animal health the past 18 months is providing new capital to support innovation to solve various health conditions in animals. New health issues continue to evolve such as the new PEDV (porcine epidemic diarrhea virus) hitting the US pork industry. These new diseases offer opportunities for new diagnostics, vaccines and therapies. Mother Nature’s evolving “bugs” that infect animals and humans provides a bright future for the industry.
Have a great weekend and stay warm!!
ロン・ブラッケ
**********************************
この電子ニュースレターは、Brakke Consulting, Inc. の独占所有物です。
ここに記載されている内容の使用は、Brakke Consulting, Inc. の承認を得て、Brakke Consulting, Inc. に適切に帰属させる必要があります。
Brakke Consultingのサービスとシンジケート調査の詳細については、当社のウェブサイトをご覧ください。 ホームページ.
ブラッケコンサルティング株式会社
12005 フォード ロード、スイート 530
ダラス、テキサス州 75234 米国
Japanese 
English 
Portuguese 
Chinese